Mesoblast (MESO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Mesoblast Revenue Highlights


Latest Revenue (Y)

$7.50M

Latest Revenue (Q)

$1.69M

Main Geography (Y)

AUSTRALIA

Mesoblast Revenue by Period


Mesoblast Revenue by Year

DateRevenueChange
2023-06-30$7.50M-26.54%
2022-06-30$10.21M36.95%
2021-06-30$7.46M-76.81%
2020-06-30$32.16M92.30%
2019-06-30$16.72M-3.57%
2018-06-30$17.34M618.95%
2017-06-30$2.41M-94.33%
2016-06-30$42.55M79.16%
2015-06-30$23.75M-8.59%
2014-06-30$25.98M-9.75%
2013-06-30$28.79M-24.80%
2012-06-30$38.28M-68.34%
2011-06-30$120.92M2198468.82%
2010-06-30$5.50K-99.38%
2009-06-30$890.71K-2.10%
2008-06-30$909.81K-45.82%
2007-06-30$1.68M-40.49%
2006-06-30$2.82M461.11%
2005-06-30$502.88K-

Mesoblast generated $7.50M in revenue during NA 2023, up -26.54% compared to the previous quarter, and up 43.26% compared to the same period a year ago.

Mesoblast Revenue by Quarter

DateRevenueChange
2023-12-31$1.69M-
2023-09-30$1.69M-20.80%
2023-06-30$2.14M10.31%
2023-03-31$1.94M-2.07%
2022-12-31$1.98M37.21%
2022-09-30$1.44M-35.12%
2022-06-30$2.22M10.59%
2022-03-31$2.01M-15.58%
2021-12-31$2.38M-33.72%
2021-09-30$3.59M80.06%
2021-06-30$2.00M4.34%
2021-03-31$1.91M-14.45%
2020-12-31$2.24M73.47%
2020-09-30$1.29M86.27%
2020-06-30$692.00K-94.27%
2020-03-31$12.08M513.56%
2019-12-31$1.97M-88.33%
2019-09-30$16.87M757.75%
2019-06-30$1.97M57.49%
2019-03-31$1.25M-33.21%
2018-12-31$1.87M-83.93%
2018-09-30$11.64M584.53%
2018-06-30$1.70M71.54%
2018-03-31$991.00K-92.54%
2017-12-31$13.28M1031.43%
2017-09-30$1.17M107.42%
2017-06-30$566.00K-37.18%
2017-03-31$901.00K63.82%
2016-12-31$550.00K39.24%
2016-09-30$395.00K-98.53%
2016-06-30$26.88M548.94%
2016-03-31$4.14M3.19%
2015-12-31$4.01M-46.57%
2015-09-30$7.51M-7.96%
2015-06-30$8.16M86.50%
2014-12-31$4.38M-

Mesoblast generated $1.69M in revenue during Q2 2024, up 0.00% compared to the previous quarter, and up 117.39% compared to the same period a year ago.

Mesoblast Revenue Breakdown


Mesoblast Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 20
AUSTRALIA$20.00M

Mesoblast's latest annual revenue breakdown by geography, as of Jun 20: AUSTRALIA (100.00%).

Mesoblast Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FBIOFortress Biotech$59.66M$14.63M
ETONEton Pharmaceuticals$31.64M$10.32M
FENCFennec Pharmaceuticals$21.64M$6.97M
HOOKHOOKIPA Pharma$20.13M-
MESOMesoblast$7.50M$1.69M
VRCAVerrica Pharmaceuticals$5.12M$-1.86M
ADTXAditxt$645.18K$6.85K
LPCNLipocine$109.99K$89.56K
APTOAptose Biosciences--
XFORX4 Pharmaceuticals-$560.00K
MBIOMustang Bio--
DAWNDay One Biopharmaceuticals-$20.07M
CNTBConnect Biopharma--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ACHLAchilles Therapeutics--
LRMRLarimar Therapeutics--
NUVBNuvation Bio-$727.00K
ELDNEledon Pharmaceuticals--

MESO Revenue FAQ


What is Mesoblast’s yearly revenue?

Mesoblast's yearly revenue for 2023 was $7.5M, representing a decrease of -26.54% compared to 2022. The company's yearly revenue for 2022 was $10.21M, representing an increase of 36.95% compared to 2021. MESO's yearly revenue for 2021 was $7.46M, representing a decrease of -76.81% compared to 2020.

What is Mesoblast’s quarterly revenue?

Mesoblast's quarterly revenue for Q2 2024 was $1.69M, a 0% increase from the previous quarter (Q1 2024), and a -14.44% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.69M, a -20.80% decrease from the previous quarter (Q4 2023), and a 17.39% increase year-over-year (Q1 2023). MESO's quarterly revenue for Q4 2023 was $2.14M, a 10.31% increase from the previous quarter (Q3 2023), and a -3.82% decrease year-over-year (Q4 2022).

What is Mesoblast’s revenue growth rate?

Mesoblast's revenue growth rate for the last 3 years (2021-2023) was 0.60%, and for the last 5 years (2019-2023) was -55.14%.